Global “Post-operative Pain Management Market” Future Scope 2023-2032, With Top Trend

Global Post-Operative Pain Management Market- Description
Post-operative pain management is predominantly referred to as the use of a wide array of therapies or drugs to reduce muscle and tissue spasm in patients who have recently undergone a surgical procedure. It is evident that all type of surgeries, be it major or minor cause postoperative pain in patients which in turn increases their hospital stays while burdening them with psychological and physical stress. Hence, a wide range of therapeutics have been developed to keep such pains at bay. Some of the commonly used post-surgery pain management drugs are cox inhibitors, opioids, and anesthetics, among others.

Global Post-Operative Pain Management Market- Overview
The global post-operative pain management market was worth USD 35.5 billion in 2021 and is expected to register a CAGR of 5% over 2022-2030, thereby amassing a valuation of USD 57.8 billion by end of the assessment timeframe. The growing prevalence of chronic diseases including cancer, COPD, tumors, and kidney disorders, among others and rise in the number of surgeries across the globe are primarily augmenting the outlook of this marketplace.

Furthermore, growing cognizance regarding the benefits of surgical treatments and rapid evolution in the field of medical science are creating lucrative opportunities for the industry sphere to prosper.
Also, increasing R&D activities in the field, rising health consciousness of the masses, and widespread technological innovation in the field are adding momentum to the progression of this business vertical.
On the contrary, side effects pertaining to certain post-operative pain management drugs is hindering the remuneration scope of this marketplace.

Global Post-Operative Pain Management Market- Key Trends
Increase In The Prevalence Of Road Accidents To Aid Industry Expansion
With rapid urbanization, there has been a widespread surge in the number of vehicles on roads. This has further resulted in a steep rise in the number of road accidents powered by traffic congestion, irresponsible driving, and bad road conditions. Therefore, increase in the number of road accidents is elevating the demand for pain management therapeutics so as to reduce soreness and heavy pain caused by trauma injuries in the accident victims.

Growing Focus Market Players To Develop Efficient Drugs In The Field To Bolster Market Growth
With rise in the number of surgical treatment options for a wide array of diseases, key industry players have increased their efforts to develop efficient post-surgery pain management medications. Various biopharmaceutical companies have created abuse-deterrent opioid drugs and extended-release non-opioid drugs which have shown positive results in the field of post-operative pain management. This in turn is creating an upward trend for the industry progression.

Global Post-Operative Pain Management Market- Segmental Assessment
By Type
• Acute Pain Management
• Moderate Pain Management
• Severe Pain Management
The severe pain management segment is slated to generate significant returns over 2022-2030. This is credited to the rise in the number of patients having trauma injuries.

By Application
• Cancer Pain
• Arthritic Pain
• Neuropathic Pain
• Musculoskeletal Pain
• Migraine Pain
• Others
The cancer pain segment is poised to amass notable gains over the estimated timeframe ascribed to the rising pervasiveness of the diseases coupled with the emergence of various surgical treatments for the same.

Global Post-Operative Pain Management Market- Geographical Landscape
North America, Middle East & Africa, Europe, Latin America, and Asia Pacific are the major regions constituting the geographical ambit of this business vertical. Among these, North America is projected to capture a substantial revenue share over 2022-2030. This is attributable to the rising healthcare expenditure, increase in the number of surgeries, growing prevalence of chronic ailments, and presence of strong industry players.

Key segments reported-
• By Type (Acute Pain Management, Moderate Pain Management, and Severe Pain Management)
• By Application (Cancer Pain, Arthritic Pain, Neuropathic Pain, Musculoskeletal Pain, Migraine Pain, and Others)

Major regions and countries covered-
• North America (U.S. and Canada)
• Asia Pacific (China, Japan, Australia, South Korea, and India)
• Latin America (Columbia, Mexico, Argentina, and Brazil)
• Middle East & Africa (UAE, Egypt, and South Africa)
• Europe (U.K., France, Germany, Russia, and Italy)

Top players profiled- Eli Lilly, Pfizer, Purdue Pharma, Endo Pharmaceuticals Plc., Forest Laboratories, Inc., Teva Pharmaceutical Industries Ltd., Johnson & Johnson, GlaxoSmithKline, F. Hoffman-La Roche Ltd., and Baxter International, Inc.